Andrew Dahl - Zivo Bioscience CEO Pres
| ZIVOWDelisted Stock | USD 0.55 0.07 14.58% |
Insider
Andrew Dahl is CEO Pres of Zivo Bioscience Warrants
| Age | 70 |
| Phone | 248 452 9866 |
| Web | https://www.zivobioscience.com |
Andrew Dahl Latest Insider Activity
Tracking and analyzing the buying and selling activities of Andrew Dahl against Zivo Bioscience stock is an integral part of due diligence when investing in Zivo Bioscience. Andrew Dahl insider activity provides valuable insight into whether Zivo Bioscience is net buyers or sellers over its current business cycle. Note, Zivo Bioscience insiders must abide by specific rules, including filing SEC forms every time they buy or sell Zivo Bioscience'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Andrew Dahl over a month ago Disposition of 4559 shares by Andrew Dahl of Edwards Lifesciences at 87.62 subject to Rule 16b-3 | ||
Andrew Dahl over a month ago Disposition of 4559 shares by Andrew Dahl of Edwards Lifesciences at 87.62 subject to Rule 16b-3 | ||
Andrew Dahl over two months ago Disposition of 4559 shares by Andrew Dahl of Edwards Lifesciences at 87.62 subject to Rule 16b-3 | ||
Andrew Dahl over two months ago Disposition of 4559 shares by Andrew Dahl of Edwards Lifesciences at 87.62 subject to Rule 16b-3 |
Zivo Bioscience Management Efficiency
The company has return on total asset (ROA) of (1.6474) % which means that it has lost $1.6474 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (39.5602) %, meaning that it generated substantial loss on money invested by shareholders. Zivo Bioscience's management efficiency ratios could be used to measure how well Zivo Bioscience manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 9 records | INSIDER Age | ||
| CPA CPA | GeoVax Labs | 62 | |
| Mark Newman | GeoVax Labs | 69 | |
| John Docherty | Lexaria Bioscience Corp | 55 | |
| Christopher Bunka | Lexaria Bioscience Corp | 62 | |
| Harriet Robinson | GeoVax Labs | 86 | |
| FACP MD | BriaCell Therapeutics Corp | 78 | |
| Farrah Dean | BriaCell Therapeutics Corp | N/A | |
| Philip Ainslie | Lexaria Bioscience Corp | N/A | |
| Vanessa Carle | Lexaria Bioscience Corp | N/A | |
Management Performance
| Return On Equity | -39.56 | ||||
| Return On Asset | -1.65 |
Zivo Bioscience Warrants Leadership Team
Elected by the shareholders, the Zivo Bioscience's board of directors comprises two types of representatives: Zivo Bioscience inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Zivo. The board's role is to monitor Zivo Bioscience's management team and ensure that shareholders' interests are well served. Zivo Bioscience's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Zivo Bioscience's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Casey Fowler, VP Devel | ||
| John Payne, CEO President | ||
| David Lafond, VP Technology | ||
| Harlan III, Vice Supply | ||
| Keith Marchiando, Treasurer CFO | ||
| Andrew Dahl, CEO Pres | ||
| Scott Freeman, Chief Officer |
Zivo Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Zivo Bioscience a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -39.56 | ||||
| Return On Asset | -1.65 | ||||
| Operating Margin | (133.25) % | ||||
| Number Of Shares Shorted | 5.63 K | ||||
| EBITDA | (8.73 M) | ||||
| Net Income | (8.75 M) | ||||
| Total Debt | 445.18 K | ||||
| Cash Flow From Operations | (7.1 M) | ||||
| Beta | 0.24 | ||||
| Market Capitalization | 35.33 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Consideration for investing in Zivo Stock
If you are still planning to invest in Zivo Bioscience Warrants check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Zivo Bioscience's history and understand the potential risks before investing.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |